BlackRock, Inc. 13D and 13G filings for Dyne Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-08 5:31 pm Unchanged | 2024-09-30 | 13G | Dyne Therapeutics, Inc. DYN | BlackRock Inc. BLK | 7,794,217 7.800% | 0 (Unchanged) | Filing |
| 2024-10-22 3:24 pm Purchase | 2024-09-30 | 13G | Dyne Therapeutics, Inc. DYN | BlackRock Inc. BLK | 7,794,217 7.800% | 4,005,535 (+105.72%) | Filing |
| 2024-01-29 3:26 pm Purchase | 2023-12-31 | 13G | Dyne Therapeutics, Inc. DYN | BlackRock Inc. BLK | 3,788,682 6.200% | 1,195,158 (+46.08%) | Filing |
| 2023-02-09 11:01 am Sale | 2023-01-31 | 13G | Dyne Therapeutics, Inc. DYN | BlackRock Inc. BLK | 2,593,524 4.900% | -25,094 (-0.96%) | Filing |
| 2023-02-08 2:57 pm Purchase | 2022-12-31 | 13G | Dyne Therapeutics, Inc. DYN | BlackRock Inc. BLK | 2,618,618 5.000% | 2,618,618 (New Position) | Filing |